US 11602551
Use of inosine for the treatment of t-reg deficiency
granted A61KA61K31/708A61K35/747
Quick answer
US patent 11602551 (Use of inosine for the treatment of t-reg deficiency) held by The Board of Regents of the University of Texas System expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/708, A61K35/747, A61P, A61P37/00